News Home

Analyst Rating: Will Sio Gene Therapies Inc (SIOX) Stock Lead the Market?

Wednesday, December 08, 2021 11:30 AM | InvestorsObserver Analysts
Analyst Rating: Will Sio Gene Therapies Inc (SIOX) Stock Lead the Market?

Wall Street is positive on Sio Gene Therapies Inc (SIOX). On average, analysts give Sio Gene Therapies Inc a Strong Buy rating. The average price target is $8.583, which means analysts expect the stock to climb by 472.20% over the next twelve months. That average ranking earns Sio Gene Therapies Inc an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.

Overall Score - 5
Wall Street analysts are rating SIOX a Strong Buy today. Find out what this means to you and get the rest of the rankings on SIOX!

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions **before** a quarterly report that could be worse than expected. InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Sio Gene Therapies Inc Stock Today?

Sio Gene Therapies Inc (SIOX) stock is higher by 3.82% while the S&P 500 is down -0.13% as of 11:29 AM on Wednesday, Dec 8. SIOX has risen $0.05 from the previous closing price of $1.44 on volume of 107,491 shares. Over the past year the S&P 500 has gained 26.43% while SIOX is down -41.18%. SIOX lost -$0.70 per share the over the last 12 months. Click Here to get the full Stock Report for Sio Gene Therapies Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App